As the regulatory burden in medtech grows, a structured approach to using generative AI can provide dramatic gains in efficiency, accuracy, and other key metrics.
Education
- MBA, Babson College
- MS, high honors, biomedical engineering, Case Western Reserve University
- BS, biomedical engineering, Cornell University
A core member of Boston Consulting Group's Health Care practice, Meghna Eichelberger has considerable expertise within all medical technology (MedTech) topics, including product development, strategy, regulatory, and commercialization. She is a member of the MedTech leadership team, and serves as the global marketing lead for MedTech, as well as the lead for the diabetes segment.
Since joining the firm in 2013, Meghna has accrued experience in capital equipment, software/digital, disposables, and services, as well as in the cardiac, diabetes, and sleep spaces. She has led projects in next-gen marketing and launch excellence; innovation, regulatory, quality, and market access; digital strategy and digital therapeutic business strategy and go-to-market, and more. In addition, Meghna has a deep interest in climate and sustainability and has supported MedTech executives as they define their ESG ambitions.
Prior to joining BCG in 2013, Meghna spent eight years at C.R. Bard in strategic marketing, program management, and business development roles. She also spent four years at Philips Healthcare in 3D cardiac ultrasound and two years at Cambridge Heart focused on sudden cardiac death.
